Ex vivo study ranks A2-B-H peptide combination highest for MRSA immune response
The exploratory work used cells from a single donor and did not assess protection against infection or vaccine efficacy.
PR
By Priya Raman · Science Reporter
Oct 20 18:03 ETSource: Bioengineer.org
The wire
- 01An exploratory ex vivo study found the A2-B-H MRSA virulence-factor peptide combination produced the strongest integrated immune-response profile among those tested.
- 02Peptide-based antigen selection is an early step in MRSA vaccine work, a field with no approved product to date.
- 03The study used cells from one donor and tested immune readouts only, not clinical protection, so the ranking carries no efficacy implication.
From the source
Read at bioengineer.orgMRSA virulence-factor peptide combination shows strongest immune-response
An exploratory single-donor ex vivo study found that the A2-B-H MRSA peptide combination had the strongest integrated immune-response profile, but it did not test clinical protection or vaccine efficacy.
